ARCHIVES

Cyclamate Committee Finds No Proof Of Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Seeks Better Ways to Make Available Fresh Tissue; Iverson Heads Cancer Control Science

October 5, 1984

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

State Cancer Incidence Report Published by NCI, CDC

November 22, 2002

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008